Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Vorapaxar on Thrombin Generation and Coagulability

NCT03207451 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.

NCT NCT03207451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03207451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Vorapaxar on Thrombin Generation and Coagulability
Lead sponsor
Inova Health Care Services
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2016
Completion date
August 1, 2018
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, myocardial infarction, peripheral vascular disease